Axovant Gene Therapies Ltd (NASDAQ:AXGT)

6.42
Delayed Data
As of 4:00pm ET
 -0.34 / -5.03%
Today’s Change
3.81
Today|||52-Week Range
20.80
-19.43%
Year-to-Date
No recent news for Axovant Gene Therapies Ltd.

Today’s Trading

Previous close6.76
Today’s open6.65
Day’s range6.35 - 6.84
Volume114,779
Average volume (3 months)514,671
Market cap$157.4M
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+51.36%
Earnings growth (this year)+51.98%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
EMMAEmmaus Life Sciences...+0.01+0.31%
ACORAcorda Therapeutics ...-0.06-1.89%
NBRVNabriva Therapeutics...-0.09-4.35%
OSMTOsmotica Pharmaceuti...-0.22-7.28%
Data as of 4:00pm ET, 08/23/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$1.04
Annual revenue (last year)$0.00
Annual profit (last year)-$129.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pavan Cheruvu
Senior VP-Commercial Strategy &
Operations
Parag Meswani
Corporate headquarters
London, London & South East

Forecasts